Erik Greb

Erik Greb joined the staff of Neurology Reviews in January 2012. Since then, he has attended scientific conferences, conducted video interviews, and written about clinical research in multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurologic disorders. In addition to news articles, Erik has written investigative stories about multiple sclerosis, headache, and epilepsy. He previously wrote about pharmaceutical manufacturing, drug formulation and delivery, quality assurance, and regulation for Pharmaceutical Technology.

News

Researchers identify a cause of L-DOPA–induced dyskinesia in Parkinson’s disease

Author:: Erik Greb

Publish date: May 5, 2020

The identification of a protein that contributes to abnormal involuntary movements may enable the development of improved treatments for Parkinson’...

News

Economic burden of migraine increases with the number of treatment failures

Author:: Erik Greb

Publish date: May 1, 2020

Total medical visit costs and total prescription costs are highest among patients with three or more treatment failures.

News

Prior head injury is associated with severe Parkinson’s disease phenotype

Author:: Erik Greb

Publish date: April 30, 2020

Head injury before diagnosis was associated with greater motor and nonmotor symptom burden in an analysis of two patient cohorts.

News

Financial incentives affect the adoption of biosimilars

Author:: Erik Greb

Publish date: April 23, 2020

Adoption of infliximab biosimilars proceeded more slowly at an academic medical center than at a neighboring VAMC, where financial incentives to us...

News

Financial incentives affect the adoption of biosimilars

Author:: Erik Greb

Publish date: April 16, 2020

Adoption of infliximab biosimilars proceeded more slowly at an academic medical center than at a neighboring VAMC, where financial incentives to us...

News

How do neurologists choose an acute treatment for migraine?

Author:: Erik Greb

Publish date: April 16, 2020

STOWE, VT. – The route of administration, the medicine’s tolerability, and the patient’s preferences all must be considered to enable effective tre...

News

Database will collect data on COVID-19 in patients with MS

Author:: Erik Greb

Publish date: April 16, 2020

A registry is gathering information on patients throughout the United States with a view to understanding outcomes and improving treatment.

News

American Lung Association announces $25 million initiative to end COVID-19

Author:: Erik Greb

Publish date: April 10, 2020

The initiative will fund research, improve public health measures, and promote preparedness for future respiratory virus pandemics.

News

Amid coronavirus concerns, researchers urge mental health interventions for patients with dementia

Author:: Erik Greb

Publish date: April 9, 2020

The response of dementia experts and mental health professionals in China to the COVID-19 pandemic could inform interventions worldwide for patient...